Followers | 37 |
Posts | 4190 |
Boards Moderated | 0 |
Alias Born | 10/18/2016 |
Friday, October 13, 2017 11:02:01 AM
AppSwarm, Inc. (OTC: SWRM), a high-tech acceleration firm in the multiplatform games industry, divided into two divisions in mid-August 2017 when it acquired MediaPlay and is now poised to play a more significant international role in the large, fast-growing global mobile gaming market. AppSwarm remains one company following its restructuring, but now targets a large global market via: MediaPlay, a games publisher focused internationally on larger projects, including supplying services to television channels; and Incubation and Acquisition Development (IAD), focused on acquisitions, pursuing gaming opportunities, and offering e-commerce business solutions to bolster SWRM’s organic and new growth. An article discussing this reads: “(Company CEO and Director Ron Brewer) said in an interview (http://nnw.fm/M47Ps) that his management team projects sales of $6-7 million by FY2018. The company recently entered into a joint venture with Estorerunner, a nationally franchised ‘on-demand’ delivery service for local grocery stores and pharmacies. AppSwarm also recently announced that it is developing a proprietary ‘last-mile’ delivery app platform ‘for management and implementation needs that create highly enhanced efficiencies’ (http://nnw.fm/VhBC3).”
To view the full article, visit http://nnw.fm/QkZ28
About AppSwarm
We develop and publish mobile gaming apps, with a focus on accelerating the development of free to play mobile games and fast-track them to market. We partner with game developers through joint ventures, royalty agreements, marketing partnerships, and outright purchases through our publicly-traded company on the OTC Markets, ticker SWRM. For more information, visit us at www.App-Swarm.com
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM